Company Announcements

Exercise of Warrants

Source: RNS
RNS Number : 8859I
Empyrean Energy PLC
21 April 2022
 

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

 

Empyrean Energy plc

 

Exercise of Warrants

 

21 April 2022

 

Empyrean Energy ("Empyrean" or the "Company"), the oil and gas development company with interests in China, Indonesia and the United States, advises that it has received a notice to exercise warrants (exercise price 9p per Warrant) over a total of 850,000 Ordinary Shares (the "Warrant Shares"), for which funds of £76,500 have been received by the Company.

 

Application will be made for the admission of the Warrant Shares to trading on AIM ("Admission"). Admission is expected to take place on or around 27 April 2022. The Warrant Shares will rank pari passu with the existing ordinary shares on issue.

 

Following Admission, the Company's enlarged issued share capital will comprise 666,681,891 ordinary shares of 0.2p each (the "Shares"), each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

-ENDS-

 

 

For further information please contact the following:

 

  Empyrean Energy plc


  Tom Kelly

Tel: +61 6146 5325





  Cenkos Securities plc (Nominated Advisor and Broker)


  Neil McDonald

Tel: +44 (0) 131 220 9771

  Pete Lynch

Tel: +44 (0) 131 220 9772

  Pearl Kellie

Tel: +44 (0) 131 220 9775


 

  First Equity Limited (Joint Broker)


  Jason Robertson

Tel: +44 (0) 20 7330 1883






 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEIBMRTMTJTMAT